Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8+ T-cell responses that home to the tumor site

Journal of Virology

Volumn 75, Issue 20, 2001, Pages 9654-9664

  Lamikanra, A ^a   Pan, Z K ^a   Isaacs, S N ^a   Wu, T C ^a   Paterson, Y ^a  

^a 323 Johnson Pavilion ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; HYBRID PROTEIN; LISTERIOLYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACE7; VACLLOE7; VACSIGE7LAMP 1; VIRULENCE FACTOR; VIRUS PROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL IMMORTALIZATION; HUMAN PAPILLOMAVIRUS TYPE 16; LISTERIA MONOCYTOGENES; LYMPHOCYTE SUBPOPULATION; LYSIS; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; SPLEEN CELL; VACCINIA VIRUS;

ANIMALS; ANTIGENS, CD; BACTERIAL TOXINS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC VECTORS; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; LYMPHOCYTE COUNT; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECOMBINATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VACCINES, DNA; VACCINIA VIRUS;

EID: 0034802089     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.20.9654-9664.2001     Document Type: Article

References (47)

1. MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines
2. Human interferon-inducible protein is a potent inhibitor of angiogenesis in vivo
3. Cellular responses to interferon-γ
4. Post-translational protein translation: Not all HSC70s are created equal
5. Coordinate regulation of complex T cell populations responding to bacterial infection
6. + T cells during the primary immune response to Epstein Barr virus
7. Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinat virus plaques
8. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP-70 gene
9. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen
10. Human 60-kDa heat shock protein: A danger signal to the innate immune system
11. A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity
12. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages
13. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells
14. Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16
15. Role of listeriolysin in cell-to-cell spread of Listeria monocytogenes
16. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype: An adaptive component of NK cell-mediated responses
17. In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4+ T cell dependent
18. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment
19. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells
20. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophage
21. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
22. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
23. Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7
24. Attenuated mutants of the intracellular bacterium Listeria monocytogenes obtained by single amino acid substitutions in listeriolysin O
25. Counting antigen specific CD8 T cells: A reevaluation of bystander activation during viral infection
26. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours
27. Crucial role of TNF-α in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo
28. PEST sequences and regulation by proteolysis
29. Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83
30. + T cells mediate CD40-independent maturation of dendritic cells in vivo
31. Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism
32. Mig, the monokine induced by interferon gamma, promotes tumor necrosis in vivo
33. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multiple paradigm
34. Heterotransplantation of early B-lineage acute lymphoblastic leukemia using a solubilized attachment matrix (Matrigel)
35. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway
36. + T cells in response to MIP-1α and MIP-1β
37. α and β Chemokines induce NK cell migration and enhance NK-mediated cytolysis
38. Human papillomavirus vaccines for cervical cancer
39. A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants
40. A "public" T-helper epitope of E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes
41. Degradation of T cell receptor (TCR)-CD3-ζ complexes after antigenic stimulation
42. Induction of potent antitumor CTL responses by recombinant vaccinia encoding Melan-A peptide analogue
43. Listeria monocytogenes. A potent vaccine vector for neoplastic and infectious disease
44. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens
45. Proteosomes are regulated by interferon γ: Implications for antigen processing
46. Isolation of high avidity melanoma-reactive CTL from heterogenous populations using peptide-MHC tetramers
47. Human papillomaviruses in the pathogenesis of anogenital cancer